Further experiments demonstrated that SATB2 is rarely expressed in glioma cells expressing the differentiation markers (GFAP, TUBB3, and GALC) in human GBMs (Appendix Fig S2B–G). The gene discussed is GALC; the disease is central nervous system cancer.